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Background: Pneumocystis pneumonia (PCP), caused by the
fungus Pneumocystis jirovecii, is a major cause of hospitalization
and mortality in HIV-infected patients presenting to public-sector
hospitals in South Africa. Microbiological diagnosis currently relies
on immunoﬂuorescent (IF) staining of lower respiratory tract (LRT)
samples, which may be difﬁcult to obtain. Diagnosis on upper
respiratory tract (URT) specimens using PCR technology has been
reported useful but cost is a common limitation to implementing
many of these PCR methods in resource-limited settings. The main
objectives of the study was (1) to optimise and validate an inex-
pensive, SYBR green-mediated (probe-free), real-time PCR assay,
targeting themajor surface glycoprotein (MSG) gene, for the detec-
tion of P. jirovecii in a variety of respiratory samples compared to
IF, and (2) to sequence the dihydropteroate synthase (DHPS) locus
of PCR positive samples and characterize the genotypes of the cir-
culating strains.
Methods & Materials: Upper and lower respiratory samples
referred to the laboratory at Tygerberg Hospital between August
and October 2013, from adult and paediatric patients with sus-
pected PCP, were submitted for real-time PCR and IF. Specimens
from patients with conﬁrmed viral lower respiratory tract infec-
tions were used as a control group. The fas gene, encoding the
enzyme DHPS, was ampliﬁed and sequenced from the PCR pos-
itive samples to determine wild-type strain versus with those
non-synonymous point mutations associated with sulphonamide-
resistance.
Results: 70 respiratory samples were collected for the vali-
dation. The overall detection rate by PCR (43%) was higher than
by IF (22%). The assay had a sensitivity of 100% (95% CI: 100 - 100%)
and a speciﬁcity of 74.1% (95% CI: 60.5 - 87.7%). The control group
had a 16.7% positivity rate with PCR. Sequencing performed on 30
PCR positive samples revealed that 73.3% were wild-type strains.
Conclusion: SYBR green-mediated, real-time PCR is a reliable
and rapid PCR method that may be used to replace IF for the rou-
tine diagnosis of PCP. A more detailed molecular epidemiological
study, to includea larger sample size, informationon sulphonamide
exposure and clinical outcome, is warranted in our setting.
http://dx.doi.org/10.1016/j.ijid.2014.03.1191
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Direct Manual Antibiotic Susceptibility Tests
(DMAST) compared with Minimal Inhibitory
Concentration (MIC) System: Reliable results in
8 to 18hours
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Background: Conﬁrmation of a pathogen’s susceptibility to an
antimicrobial is essential to achieve the best treatment approach.
Antibiotic Susceptibility Tests (AST) includes manual and auto-
mated techniques, Minimal Inhibitory Concentration (MIC) which
require 3 to 5 days for AST results; the Direct Manual AST (DMAST)
method shortens this result time window, without decreasing the
speciﬁcity or sensitivity of current AST approaches. Time is cru-
cial in day-to-day clinical practice, especially in bacterial infections
which can lead to numerous pathological consequences and antibi-
otic misuse and resistance.
Methods & Materials: DMAST modiﬁes the CLSI (Clinical and
Laboratory Standards Institute) disc diffusion tests using urine
samples. In this protocol, DMAST was used in urine samples, fol-
lowing the direct smear process on a Mueller Hinton Agar Petri
dish; this allows obtaining results in only 8 to 18hours after sam-
ple collection. Each DMAST sample was analyzed after 8hours and
18hours incubation at 37◦C. In order, to compare the reliability
of this new technique DMAST with MIC system, the same sample
was processed as the micro dilution MIC method, it was used the
Phoenix 100 equipment; the results were analyzed in 3 to 8 days.
This study was done in 62 samples per group ages ranged from: 9
months to 92 years old, 47 female and15male cases,were analyzed
in each AST inhibition zone in described time window.
Results: Overall, agreement between the two methods was:
DMAST with Gram negative bacteria in urine colony counts
>100.000 UCF/mL compared with the MIC system. Statistically
parameters: Sensitivity 97.9%, Speciﬁcity 81.8%, PPV (Positive Pre-
dictive Value) 99.5% and NPV (Negative Predictive Value) 44.4%
and showedno statistical differences, probability of > 0.09 between
DMAST and MIC (p>0.09).
Conclusion: Daily clinical practice requires optimal diagnos-
tic methods decreasing the use of wide spectrum antibiotics and
health costs. DMAST reliably presents results in an earlier time
window (saving around 64-120hours for diagnosis) than MIC pro-
cedures.The present study suggests the initial DMAST can give
sensitivity results in 8-18hours for urgent cases and late MIC for
conﬁrmatory purposes.
http://dx.doi.org/10.1016/j.ijid.2014.03.1192
